417 related articles for article (PubMed ID: 30875781)
41. Human Pluripotent Stem Cell-Derived Hepatocyte-Like Cells and Organoids for Liver Disease and Therapy.
Li Y; Yang X; Plummer R; Hayashi Y; Deng XS; Nie YZ; Taniguchi H
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638810
[TBL] [Abstract][Full Text] [Related]
42. Dynamic 3D Combinatorial Generation of hPSC-Derived Neuromesodermal Organoids With Diverse Regional and Cellular Identities.
Whye D; Wood D; Kim KH; Chen C; Makhortova N; Sahin M; Buttermore ED
Curr Protoc; 2022 Oct; 2(10):e568. PubMed ID: 36264199
[TBL] [Abstract][Full Text] [Related]
43. Development of a protocol for maintaining viability while shipping organoid-derived retinal tissue.
Singh RK; Winkler P; Binette F; Glickman RD; Seiler M; Petersen-Jones SM; Nasonkin IO
J Tissue Eng Regen Med; 2020 Feb; 14(2):388-394. PubMed ID: 31908157
[TBL] [Abstract][Full Text] [Related]
44. Generating Kidney Organoids from Human Pluripotent Stem Cells Using Defined Conditions.
Howden SE; Little MH
Methods Mol Biol; 2020; 2155():183-192. PubMed ID: 32474877
[TBL] [Abstract][Full Text] [Related]
45. Generation of human colonic organoids from human pluripotent stem cells.
Daoud A; Múnera JO
Methods Cell Biol; 2020; 159():201-227. PubMed ID: 32586443
[TBL] [Abstract][Full Text] [Related]
46. Bidirectional cell-matrix interaction dictates neuronal network formation in a brain-mimetic 3D scaffold.
Samanta S; Ylä-Outinen L; Rangasami VK; Narkilahti S; Oommen OP
Acta Biomater; 2022 Mar; 140():314-323. PubMed ID: 34902615
[TBL] [Abstract][Full Text] [Related]
47. Development of a three-dimensional organoid model to explore early retinal phenotypes associated with Alzheimer's disease.
Lavekar SS; Harkin J; Hernandez M; Gomes C; Patil S; Huang KC; Puntambekar SS; Lamb BT; Meyer JS
Sci Rep; 2023 Aug; 13(1):13827. PubMed ID: 37620502
[TBL] [Abstract][Full Text] [Related]
48. Three-Dimensional Renal Organoids from Whole Kidney Cells: Generation, Optimization, and Potential Application in Nephrotoxicology In Vitro.
Ding B; Sun G; Liu S; Peng E; Wan M; Chen L; Jackson J; Atala A
Cell Transplant; 2020; 29():963689719897066. PubMed ID: 32166969
[TBL] [Abstract][Full Text] [Related]
49. Advances in Central Nervous System Organoids: A Focus on Organoid-Based Models for Motor Neuron Disease.
Vieira de Sá R; Cañizares Luna M; Pasterkamp RJ
Tissue Eng Part C Methods; 2021 Mar; 27(3):213-224. PubMed ID: 33446055
[TBL] [Abstract][Full Text] [Related]
50. Optimization of cerebral organoids: a more qualified model for Alzheimer's disease research.
Bi FC; Yang XH; Cheng XY; Deng WB; Guo XL; Yang H; Wang Y; Li J; Yao Y
Transl Neurodegener; 2021 Aug; 10(1):27. PubMed ID: 34372927
[TBL] [Abstract][Full Text] [Related]
51. Retinal organoids in disease modeling and drug discovery: Opportunities and challenges.
Chakrabarty K; Nayak D; Debnath J; Das D; Shetty R; Ghosh A
Surv Ophthalmol; 2024; 69(2):179-189. PubMed ID: 37778668
[TBL] [Abstract][Full Text] [Related]
52. Human iPSC-Derived Neural Models for Studying Alzheimer's Disease: from Neural Stem Cells to Cerebral Organoids.
Barak M; Fedorova V; Pospisilova V; Raska J; Vochyanova S; Sedmik J; Hribkova H; Klimova H; Vanova T; Bohaciakova D
Stem Cell Rev Rep; 2022 Feb; 18(2):792-820. PubMed ID: 35107767
[TBL] [Abstract][Full Text] [Related]
53. Generating Cerebral Organoids from Human Pluripotent Stem Cells.
Chew L; Añonuevo A; Knock E
Methods Mol Biol; 2022; 2389():177-199. PubMed ID: 34558011
[TBL] [Abstract][Full Text] [Related]
54. Efficient derivation of cortical glutamatergic neurons from human pluripotent stem cells: a model system to study neurotoxicity in Alzheimer's disease.
Vazin T; Ball KA; Lu H; Park H; Ataeijannati Y; Head-Gordon T; Poo MM; Schaffer DV
Neurobiol Dis; 2014 Feb; 62():62-72. PubMed ID: 24055772
[TBL] [Abstract][Full Text] [Related]
55. Harnessing cerebral organoids for Alzheimer's disease research.
Bubnys A; Tsai LH
Curr Opin Neurobiol; 2022 Feb; 72():120-130. PubMed ID: 34818608
[TBL] [Abstract][Full Text] [Related]
56. Generation of human cerebral organoids with a structured outer subventricular zone.
Walsh RM; Luongo R; Giacomelli E; Ciceri G; Rittenhouse C; Verrillo A; Galimberti M; Bocchi VD; Wu Y; Xu N; Mosole S; Muller J; Vezzoli E; Jungverdorben J; Zhou T; Barker RA; Cattaneo E; Studer L; Baggiolini A
Cell Rep; 2024 Apr; 43(4):114031. PubMed ID: 38583153
[TBL] [Abstract][Full Text] [Related]
57. Small-molecule induction of Aβ-42 peptide production in human cerebral organoids to model Alzheimer's disease associated phenotypes.
Pavoni S; Jarray R; Nassor F; Guyot AC; Cottin S; Rontard J; Mikol J; Mabondzo A; Deslys JP; Yates F
PLoS One; 2018; 13(12):e0209150. PubMed ID: 30557391
[TBL] [Abstract][Full Text] [Related]
58. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
Machairaki V
Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
[TBL] [Abstract][Full Text] [Related]
59. Modelling neurodegenerative disease using brain organoids.
Wray S
Semin Cell Dev Biol; 2021 Mar; 111():60-66. PubMed ID: 32513498
[TBL] [Abstract][Full Text] [Related]
60. Mesenchymal stem cells, neural lineage potential, heparan sulfate proteoglycans and the matrix.
Okolicsanyi RK; Griffiths LR; Haupt LM
Dev Biol; 2014 Apr; 388(1):1-10. PubMed ID: 24509075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
